In the BioHarmony Drug Report Database
Patiromer
Veltassa (patiromer) is a small molecule pharmaceutical. Patiromer was first approved as Veltassa on 2015-10-21. It is used to treat hyperkalemia in the USA. It has been approved in Europe to treat hyperkalemia. Veltassa’s patents are valid until 2033-10-08 (FDA).
Trade Name
|
Veltassa |
|---|---|
Common Name
|
patiromer |
ChEMBL ID
|
CHEMBL2107875 |
Indication
|
hyperkalemia |
Drug Class
|
Polymers |
Image (chem structure or protein)
